New York, NY (PRWEB) April 02, 2013
The birth control safety advocates at DrugRisk.com are announcing new information on the site for women who have taken the drugs Yaz or Yasmin. The manufacturer, Bayer, will now compensate certain patients who allege gallbladder injuries, in addition to the ongoing settlements for blood clots*.
The goal of DrugRisk is to improve patient safety by providing the latest warnings, recalls, studies and litigation news. Visitors can learn if others have experienced similar side effects and decide if they need legal help to join current litigation.
The resource center has learned that Bayer will designate $24 million to compensate patients who allege gallbladder injuries after taking Yaz or Yasmin*. While this could affect as many as 8,000 patients, payouts are only estimated at $2,000 to $3,000*.
Thousands more have filed a Yaz lawsuit alleging blood clot injuries, which were consolidated to a special federal Multi-District Litigation court in Illinois. The case is known as Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois).
Experts with the British Medical Journal and FDA have alerted patients that birth control pills containing drospirenone, like Yaz and Yasmin, can increase the risk of blood clots, DVT and pulmonary embolism by as much as 74%**.
DrugRisk has obtained the latest financial reports from Bayer, which states the company has spent nearly $1 billion to settle around 4,800 claims alleging blood clot injuries like deep vein thrombosis (DVT) or pulmonary embolism***. The average amount paid to patients for these claims is over $208,000, much higher than for gallbladder injuries.
Copyright©2012 Vocus, Inc.
All rights reserved